DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma (Q37350545)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 March 2009
edit
Language Label Description Also known as
English
DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma
scientific article published on 10 March 2009

    Statements

    DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma (English)
    Claudia-Nanette Gann
    Wolfgang E Berdel
    Herrmann Einsele
    Deutsche Studiengruppe Multiples Myelom, DSMM

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit